The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

California Institute of Regenerative Medicine and Cancer Research: A promise broken?

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Approximately 21 years ago, I had the privilege of working and helping to pass Proposition 71, which authorized $3 billion dollars in state bonds to fund stem cell research in California. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Stephen J. Forman, MD
Director, Hematologic Malignancies Research Institute, Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratory, Co-director, Hematologic Malignancies Program, City of Hope Comprehensive Cancer Center; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope
Table of Contents

YOU MAY BE INTERESTED IN

Byline
Stephen J. Forman, MD
Director, Hematologic Malignancies Research Institute, Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratory, Co-director, Hematologic Malignancies Program, City of Hope Comprehensive Cancer Center; Professor, Department of Medical Oncology & Therapeutics Research, City of Hope
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account